临床级间充质干细胞培养规范

被引:5
作者
陈津 [1 ]
马予洁 [1 ]
郭子宽 [2 ]
谭建明 [1 ]
机构
[1] 南京军区福州总医院全军器官移植研究所 福建省移植生物学重点实验室
[2] 军事医学科学院放射与辐射医学研究所实验血液学研究室
关键词
D O I
暂无
中图分类号
R329 [人体组织学];
学科分类号
100107 [人体解剖与组织胚胎学(人体解剖学、组织与胚胎学)];
摘要
<正>20世纪70年代,人们就发现了一种来源于中胚层、成纤维样贴壁生长的细胞,称之为间充质干细胞(mesenchymal stem cell,MSC)[1]。MSC因其具有多向分化潜能、免疫调节和分泌细胞因子的能力,成为研究治疗免疫疾病和组织修复等的重要工具。1995年首次报道MSC应用于临床试验,现在培养的MSC已被广泛用于临床试验研究[2],从移植物抗宿主病、充血性心衰、急性心梗、2型糖尿病、脊髓
引用
收藏
页码:144 / 148
页数:5
相关论文
共 15 条
[1]
Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells [J].
Garcia, S. ;
Bernad, A. ;
Martin, M. C. ;
Cigudosa, J. C. ;
Garcia-Castro, J. ;
de la Fuente, R. ;
Bernad, A. ;
Garcia-Castro, J. .
EXPERIMENTAL CELL RESEARCH, 2010, 316 (09) :1648-1650
[2]
Human AB Serum and Thrombin‐Activated Platelet‐Rich Plasma Are Suitable Alternatives to Fetal Calf Serum for the Expansion of Mesenchymal Stem Cells from Adipose Tissue.[J].AsliKocaoemer;SusanneKern;HaraldKlüter;KarenBieback.STEM CELLS.2009, 5
[3]
Comparison of Proliferative and Multilineage Differentiation Potential of Human Mesenchymal Stem Cells Derived from Umbilical Cord and Bone Marrow.[J].DoloresBaksh;RaphaelYao;Rocky S.Tuan.STEM CELLS.2009, 6
[4]
Study of Telomere Length Reveals Rapid Aging of Human Marrow Stromal Cells following In Vitro Expansion.[J].Melissa A.Baxter;Robert F.Wynn;Simon N.Jowitt;J. EdWraith;Leslie J.Fairbairn;IlariaBellantuono.STEM CELLS.2008, 5
[5]
Mesenchymal progenitor cells in human umbilical cord blood.[J].AlejandroErices;PauletteConget;José J.Minguell.British Journal of Haematology.2008, 1
[6]
Producing MSC according GMP: Process and controls [J].
Sensebe, Luc ;
Bourin, Philippe .
BIO-MEDICAL MATERIALS AND ENGINEERING, 2008, 18 (4-5) :173-177
[7]
Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies.[J].A. Stolzing;E. Jones;D. McGonagle;A. Scutt.Mechanisms of Ageing and Development.2007, 3
[8]
Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM [J].
Mueller, I. ;
Kordowich, S. ;
Holzwarth, C. ;
Spano, C. ;
Isensee, G. ;
Staiber, A. ;
Viebahn, S. ;
Gieseke, F. ;
Langer, H. ;
Gawaz, M. P. ;
Horwitz, E. M. ;
Conte, P. ;
Handgretinger, R. ;
Dominici, M. .
CYTOTHERAPY, 2006, 8 (05) :437-444
[9]
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement [J].
Dominici, M. ;
Le Blanc, K. ;
Mueller, I. ;
Slaper-Cortenbach, I. ;
Marini, F. C. ;
Krause, D. S. ;
Deans, R. J. ;
Keating, A. ;
Prockop, D. J. ;
Horwitz, E. M. .
CYTOTHERAPY, 2006, 8 (04) :315-317
[10]
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells [J].
Le Blanc, K ;
Rasmusson, I ;
Sundberg, B ;
Götherström, C ;
Hassan, M ;
Uzunel, M ;
Ringdén, O .
LANCET, 2004, 363 (9419) :1439-1441